Pieris Pharmaceuticals, Inc. (PIRS): $4.34

0.80 (+22.60%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PIRS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

Pieris Pharmaceuticals Inc (PIRS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Pieris Pharmaceuticals Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $9 $6 $7.5 $3.53 112.46%

The Trend in the Analyst Price Target


Over the past 17 days, PIRS's average price target has gone down $1.5.

PIRS reports an average of 235.41% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-25 2 9 6 7.50 3.76 99.47%
2021-05-22 2 9 6 7.50 1.93 288.6%
2021-05-15 2 9 9 9.00 1.88 378.72%
2021-05-08 2 9 9 9.00 1.93 366.32%
2021-04-14 2 9 9 9.00 2.09 330.62%
2021-03-08 2 9 9 9.00 2.41 273.44%
2021-03-06 2 9 9 9.00 2.57 250.19%
2021-02-27 2 9 9 9.00 2.72 230.88%
2021-01-07 3 9 5 7.67 2.78 175.9%
2020-12-30 3 9 5 7.67 2.65 189.43%
2020-12-26 3 9 5 7.67 2.74 179.93%
2020-12-19 3 9 5 7.67 2.81 172.95%
2020-11-23 3 9 5 7.67 2.82 171.99%
2020-11-04 3 9 5 7.67 2.67 187.27%
2020-04-08 3 10 5 8.00 NA NA%

PIRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 2 1 0 0 0 3

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PIRS as an investment opportunity.

  • PIRS has a higher upside potential (average analyst target price relative to current price) than 86.64% of all US stocks.
  • The average analyst price target of PIRS is higher than 14.42% of all US stocks.
  • The number of analysts covering the stock of PIRS is greater than 13.71% of Healthcare stocks.
  • PIRS has a less variance in analysts' estimates than 28.26% of stocks in the small market cap category.

In the Business Services industry, GNOG, OLB and HGBL are the three stocks most similar to Pieris Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding PIRS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8725 seconds.